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Abstract
Background: LIN-12/Notch signaling is important for cell-cell interactions during development, and mutations resulting in
constitutive LIN-12/Notch signaling can cause cancer. Loss of negative regulators of lin-12/Notch activity has the potential
for influencing cell fate decisions during development and the genesis or aggressiveness of cancer.
Methodology/Principal Findings: We describe two negative modulators of lin-12 activity in C. elegans. One gene, sel-11,
was initially defined as a suppressor of a lin-12 hypomorphic allele; the other gene, cdc-42, is a well-studied Rho GTPase.
Here, we show that SEL-11 corresponds to yeast Hrd1p and mammalian Synoviolin. We also show that cdc-42 has the
genetic properties consistent with negative regulation of lin-12 activity during vulval precursor cell fate specification.
Conclusions/Significance: Our results underscore the multiplicity of negative regulatory mechanisms that impact on lin-12/
Notch activity and suggest novel mechanisms by which constitutive lin-12/Notch activity might be exacerbated in cancer.
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Introduction
LIN-12/Notch signaling plays multiple roles in vulval develop-
ment in C. elegans. Canonical roles for this signaling system in
vulval development are the specification of a single anchor cell
(AC), which is required for vulval induction, and the specification
of the 2u vulval precursor cell (VPC) type. Numerous feedback
loops and functional redundancies make vulval development
relatively insensitive to small perturbations in signaling pathways.
Thus, an individual regulator often does not cause an overt
phenotype when it is removed in an otherwise wild-type genetic
background, but its function may be revealed when it is removed
in a sensitized genetic background. In C. elegans, a few core
components of LIN-12/Notch signaling have been identified in
phenotype-based genetic screens, but most core components and
modulators have been identified as suppressors or enhancers in
sensitized backgrounds (reviewed in [1]).
Mutations resulting in constitutive or elevated LIN-12/Notch
signaling can cause cancer (reviewed in [2,3]). In principle,
abrogation of any system of negative regulation of lin-12/Notch
activity has the potential for contributing to the development or
aggressiveness of cancer. For example, there is some evidence that
increased expression of the human SEL-1 ortholog, SEL1L,
correlates with a decrease in tumor aggressiveness (reviewed in
[4]), but how this correlation relates to effects on Notch activity is
not clear. A compelling example is afforded by the ubiquitin ligase
SEL-10/Fbw7, which targets LIN-12/Notch directly for protea-
some-mediated degradation ([5]; reviewed in [6]). Point mutations
in the extracellular domain of NOTCH1 are one cause of T cell
acute lymphoblastic leukemia (T-ALL); when patients with these
mutations relapse after chemotherapy, they generally have
mutations in FBW7. Patients presenting with NOTCH1 mutations
that remove the Fbw7 binding site do not have Fbw7 mutations
upon relapse. These observations have implicated the loss of the
negative regulation of NOTCH1 in patients whose T-ALL tumors
are drug-resistant after relapse [7].
Here, we describe two negative modulators of lin-12 activity.
One gene, sel-11, was initially defined as a suppressor of a lin-12
hypomorphic allele [8]. The other, cdc-42, is a well-studied Rho
GTPase that we find has an effect on lin-12 activity that appears to
be distinct from other roles of cdc-42 in vulval development
described previously [9]. Our results underscore the multiplicity of
mechanisms that impact on lin-12/Notch activity and suggest novel
mechanisms by which aberrations in lin-12/Notch activity might be
exacerbated in cancer.
Results
The genetic analysis of modulators of lin-12 activity involves
combinations with different lin-12 alleles. Such alleles reduce or
elevate lin-12 activity, and their effects on hallmark cell fate
decisions are shown in Fig. 1. We first describe the genetic analysis
that establishes hrd-1 as sel-11. We then describe genetic
interactions between cdc-42 and lin-12.
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encodes Hrd1p/Synoviolin
Mutations in sel-11 were originally identified in a genetic
screen for negative regulators of lin-12 activity [8]. This screen
was based on suppression of the egg-laying defective (Egl)
phenotype caused by the hypomorphic allele, lin-12(n676n930)
[10]; the properties of this allele are described further below.
Extensive genetic analysis of the interactions between sel-11 and
multiple lin-12 alleles in different cellular contexts established sel-
11 as a negative regulator of lin-12 activity, but its molecular
identity was not determined [8].
We molecularly identified sel-11 serendipitously because it is
adjacent to the microRNA gene mir-61. A previous study in our
laboratory concluded that mir-61 is expressed in response to LIN-
12 activation and targets VAV-1, a negative regulator of lin-12
activity [11]. Our view of the role of mir-61 in vulval development
was challenged by Miska et al. [12], who reported that a deletion
of mir-61, nDf59, does not cause overt vulval lineage defects. We
independently confirmed that nDf59 exhibits overtly normal vulval
development by examining canonical 1u,2 u, and 3u cell fate
markers (Table 1). However, as described below, our further
analysis of nDf59 revealed that it removed sel-11, a negative
regulator of lin-12 activity, and it is therefore problematic to use
nDf59 to draw inferences about mir-61/250 function.
The possibility that nDf59 might affect a negative regulator of
lin-12 activity arose when we examined the genetic interactions
between nDf59 and lin-12(n676n930), a hypomorphic allele of lin-
12 in which activity is compromised but not eliminated [10].
When lin-12(n676n930) hermaphrodites are grown at 25uC, they
exhibit defects caused by reduced lin-12 activity: a highly
penetrant egg-laying defect; a partially penetrant 2 AC defect;
and, in hermaphrodites with 1 AC, a partially penetrant lateral
signaling defect (P5.p and/or P7.p lose expression of a 2u fate
marker) ([10]; Fig. 2B and 2C). At 15uC, lin-12(n676n930) retains
Figure 1. Signaling events that specify Vulval Precursor Cell
(VPC) fates, and cell fate changes dependent on lin-12 activity
levels. (A) In wild-type C. elegans, vulval development is initiated in the
early L3 stage when the anchor cell (AC) signals to the underlying VPCs
via an inductive EGF signal, LIN-3 (white arrows). As a result, P6.p adopts
the 1u cell fate. P6.p, in turn, sends a lateral signal (black arrows) to its
neighboring VPCs, P5.p and P7.p, activating LIN-12 and causing them to
adopt the 2u fate. During the AC/VU fate decision in the somatic gonad,
the VU fate is determined by high lin-12 signaling. In wild-type animals,
this results in 1 AC. (B) When lin-12 activity is reduced, a VU is often not
specified, resulting in 2 ACs; in addition, as a result of increased
inductive signaling from 2 ACs and/or reduced lateral signaling due to
lower lin-12 activity, ectopic VPCs adopt the 1u fate at the expense of
the 2u fate. The lin-12(n676n930) allele shows both aspects of this
phenotype at 25uC [10]. (C) When lin-12 activity is mildly elevated, the
AC fate is lost, and a VU is specified in its place. Since the inductive
signal is lost, the underlying VPCs all adopt the 3u fate. lin-12(n379) and
lin-12(n676) are examples of weak hypermorphic alleles, as is the lin-
12(n676n930) allele at 15uC [10,18]. (D) However, when lin-12 activity is
strongly elevated, multiple VPCs are induced to adopt the 2u cell fate
even though the AC is absent [18].
doi:10.1371/journal.pone.0011885.g001
Table 1. Vulval cell fate marker expression in nDf59 is normal
compared to control animals.
1u fate marker (ayIs4 [egl-17::gfp]): scored at Pn.px
% P6.px only % No
expression
% P5.px and
P6.px
N
ayIs4 91.1 8.9 0 56
ayIs4; nDf59 96.2* 1.9 1.9 52
2u fate marker (nIs106 [lin-11::gfp]): scored at Pn.pxx
% P5.pxx and/or
P7.pxx
% P(5,6,7).pxx N
nIs106 100 0 33
nDf59; nIs106 95.5 4.5
# 44
3u fate marker (arIs101 [K09H11.1::yfp]): scored at Pn.px-Pn.pxx
% Descendants of P3.p, P4.p, and P8.p N
arIs101 100 53
nDf59; arIs101 100
& 49
*1 animal had an anteriorly shifted AC above P5.px, and accordingly expression
was seen in only P5.px.
#By Fisher’s exact test, not significantly different from nIs106 (P.0.5).
&2/49 animals had an anteriorly shifted AC located above P5.p, and accordingly
showed expression in descendants of P3.p, P7.p, and P8.p.
doi:10.1371/journal.pone.0011885.t001
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mutation. According to the proposed circuit, loss of mir-61 should
decrease lin-12 activity; thus, we would expect that nDf59 might
enhance phenotypes caused by lin-12(n676n930) at 25uC and
suppress phenotypes of lin-12(n676n930) at 15uC. However, we
obtained the opposite results, that nDf59 suppressed the loss-of-
function phenotypes of lin-12(n676n930) at 25uC, and further-
more, enhanced the weak hypermorphic phenotype of this allele at
15uC (Fig. 2B and 2C). These results indicate that nDf59 increases
lin-12 activity.
nDf59 had been reported to remove 1143 bases encompassing
mir-61 and another microRNA, mir-250 [12]. We independently
sequenced the nDf59 allele and confirmed the deletion breakpoints
reported in WormBase (www.wormbase.org). During this process,
we realized that, in addition to removing mir-61/250, nDf59 also
removes part of the adjacent protein-coding gene, hrd-1 (Fig. 2A)
(see MATERIALS AND METHODS). C. elegans hrd-1 [13] is the
ortholog of yeast HRD1, which was identified in a genetic screen
for genes that mediate HMG-CoA reductase degradation in
Saccharomyces cerevisiae [14]. Another gene defined in the same
Figure 2. nDf59 enhancement of lin-12 activity and the identification of sel-11 as hrd-1. (A) The mir-61/250 genomic region. The coding
regions for the pre-microRNAs of mir-61 and mir-250 are separated by only 44bp, making it likely that these two miRNAs are cotranscribed. Expression
of mir-61/250 in P5.p and P7.p depends on LIN-12 activation, mediated by LAG-1 Binding Sites in the 59 flanking region [11]. The thick black lines
indicate genomic regions deleted by tm1743 or nDf59 (see RESULTS). The RING domain of hrd-1/sel-11 is indicated by a grey box. Molecular lesions
were found in the RING domain of hrd-1/sel-11 for two sel-11 alleles, ar39 and ar84, as indicated by arrows. These two alleles were found to contain
point mutations in the RING finger domain of hrd-1, mutating either a histidine to a tyrosine (ar84, H312Y), or a cysteine to a tyrosine (ar39, C295Y),
thereby mutating amino acids potentially important for the ubiquitination function of the RING domain. (B, C) lin-12(n676n930) has reduced activity at
25uC and mildly elevated activity at 15uC. The VU fate in the somatic gonad is determined by high lin-12 activity, as is the 2u vulval cell fate. (B) nDf59
decreases the number of anchor cells (AC) in the lin-12(n676n930) background at both 25uC and 15uC, which indicates an enhancement of lin-12
activity. The number of ACs observed for each strain is as follows:
a 49/49 1 AC.
b 29/44 1 AC, 13/44 2 ACs, 2/44 3 ACs.
c 34/41 1 AC, 7/41 2 ACs.
d 59/
59 1 AC.
e 56/59 1 AC, 2/59 2 ACs.
f 25/42 1AC, 1/42 2 ACs. Full genotypes of animals scored for AC marker expression are unc-32(e189); arIs51[cdh-
3::gfp]; nDf59 (GS5161), unc-32(e189)lin-12(n676n930); arIs51 (GS4894), and unc-32(e189)lin-12(n676n930); arIs51; nDf59 (GS5015). (C) nDf59 increases
the number of VPCs expressing a 2u marker in the lin-12(n676n930) background at both 25uC and 15uC. When scoring for effects in the VPCs, we
scored only animals with 1 AC to avoid the influence of altered numbers of ACs on VPC fate in the lin-12(n676n930) background. In a wild-type
background, P5.p and/or P7.p express the 2u fate marker nIs106[lin-11::gfp] (Table 1, [11]). At 25uC, some lin-12(n676n930) animals have less than two
VPCs that express a 2u fate marker; this phenotype is suppressed by nDf59.A t1 5 uC, some lin-12(n676n930) animals have more than two; this
phenotype is enhanced by nDf59. Full genotypes of animals scored for expression of the nIs106[lin-11::gfp] 2u fate marker are unc-32(e189)lin-
12(n676n930); nIs106 (GS5014), and unc-32(e189)lin-12(n676n930); nDf59; nIs106 (GS5077). (D) hrd-1(tm1743), a null allele, suppresses the egg-laying
defect (Egl) of lin-12(n676n930) at 25uC. Egl: egg-laying defective.
doi:10.1371/journal.pone.0011885.g002
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molecularly characterized negative regulator of lin-12 [8,15,16].
In view of the functional relationship between HRD1 and HRD3
in yeast, we wondered if the genetic enhancement of lin-
12(n676n930) by nDf59 may be explained if hrd-1, like HRD3/sel-
1, is a negative regulator of lin-12 activity. This inference was
confirmed by showing that hrd-1(tm1743), an apparent molecular
null allele, suppresses the egg-laying defect (Egl) of lin-12(n676n930)
at 25uC (Fig. 2D).
The map position of hrd-1 suggested that it might correspond to
sel-11, previously defined as a negative regulator of lin-12 [8]. We
therefore sequenced the two available alleles of sel-11, and found
that they contain point mutations in the RING finger domain of
HRD-1 (Fig. 2A). hrd-1 has been renamed sel-11, the first
published name for the gene, in accordance with the accepted
nomenclature convention in the field. The finding that two point
mutations in the RING finger domain behave like a deletion of the
gene suggests that the ubiquitin ligase activity of SEL-11 is
important for negative regulation of lin-12 activity.
Genetic interactions implicate cdc-42 as a negative
regulator of lin-12/Notch activity
As mentioned above, nDf59 deletes the microRNA mir-250,
which appears likely to be cotranscribed with mir-61 in
response to LIN-12 activation. Using the microRNA Registry
release 2.0 prediction of the mir-250 sequence [17], we
identified potential target genes computationally, using the
same criteria that we used for mir-61 targets: we required that
39 UTRs have at least 7 bases of perfect complementarity to
the 59 end of mir-250, with this putative ‘‘seed match’’
conserved in the C. briggsae orthologs of the C. elegans genes
[11]. Our interest in cdc-42, a candidate identified in this way,
was stimulated when we found that cdc-42(RNAi) enhanced lin-
12 activity in sensitized backgrounds.
The backgrounds we used were afforded by the mild
hypermorphs lin-12(n379) and lin-12(n676) (Fig. 3A). These mild
hypermorphs lack an anchor cell and their VPCs generally behave
as wild-type VPCs do in the absence of the inductive signal, i.e.
they all adopt the 3u fate (Fig. 1). If lin-12(n379) or lin-12(n676)
activity is increased, some or all of the VPCs adopt the 2u fate,
resulting in a ‘‘Multivulva’’ phenotype that is visible in the
dissecting microscope [8,18,19] (Fig. 3A). We verified that the
Multivulva phenotype of cdc-42(RNAi); lin-12(n676) reflects an
increased number of VPCs adopting the 2u fate using a transgenic
marker (Fig. 3B). These observations are consistent with a role of
cdc-42 as a negative regulator of lin-12 activity in the VPCs.
We note that in a lin-12(+) background, cdc-42(RNAi) had been
shown to cause a supernumerary anchor cell, which induces an
extra VPC to adopt the 1u fate [9]. However, the Multivulva
phenotype of cdc-42(RNAi); lin-12(d) hermaphrodites appears to
reflect enhanced lin-12(d) activity in the VPCs rather than
supernumerary anchor cells or increased production of inductive
signal. First, cdc-42(RNAi); lin-12(n676) hermaphrodites, like
control lin-12(n676) hermaphrodites, do not have any anchor
cells: in three independent experiments, cdc-42 RNAi performed
on lin-12(n676); arIs51 animals resulted in 0/51, 0/80, 1/63 L3
Figure 3. cdc-42(RNAi) enhances lin-12 activity in the VPCs. (A) cdc-42(RNAi) enhances the Multivulva (Muv) phenotype of weak lin-12(d) alleles.
Upon RNAi treatment, cdc-42 enhanced the Muv phenotype of lin-12(n379), as well as lin-12(n676). Muv is defined as three or more ventral
protrusions. (B) The Multivulva phenotype of cdc-42(RNAi); lin-12(n676) hermaphrodites is not altered by lin-3(e1417), a mutation that reduces
inductive signal expression. Animals were scored at the L3 Pn.pxx stage, where the VPCs have divided twice. The numbers of VPCs expressing the 2u
fate marker nIs106[lin-11::yfp] are shown below. (C) A cdc-42 transcriptional reporter is expressed in the VPCs and their descendants. The
transcriptional reporter was generated by fusing the 59upstream region of cdc-42 to a 2nls-yfp reporter with an unc-54 39UTR. Expression of the
reporter was strong and uniform in all six VPCs at the Pn.p stage and was upregulated in the daughters of P5.p, P6.p and P7.p.
doi:10.1371/journal.pone.0011885.g003
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0/55 for control mCherry RNAi-treated animals. Second, the
Multivulva phenotype of cdc-42(RNAi); lin-12(n676) hermaphro-
dites is not altered by lin-3(e1417), a mutation that reduces
inductive signal expression (Fig. 3B). Third, as described above, in
cdc-42(RNAi); lin-12(n676) hermaphrodites, extra VPCs adopt the
2u fate rather than the 1u fate.
We generated a transcriptional reporter containing the 59 flanking
region of cdc-42. This reporter drives strong, uniform expression in all
six VPCs, and the level of expression appears to increase in the
daughters of P5.p, P6.p and P7.p (Fig. 3C). The presence of cdc-42 in
VPCs and their descendants is consistent with the multiple roles of cdc-
42 in VPC development and specification inferred by Welchman [9]
and the genetic interactions with lin-12 described here.
These observations are consistent with a role of cdc-42 as a
negative regulator of lin-12 activity in the VPCs. Phenotypes
caused by the expression of dominant-negative versions of
Drosophila ortholog of cdc-42 have also suggested a role as a
negative regulator of Notch signaling in wing development [20].
However, we were unable to obtain evidence that mir-250
negatively regulates cdc-42 in any assay (data not shown). When
a revised mir-250 sequence was published (miRBase 10.1, [21]), it
was evident that mir-250 has two additional adenines at its 59 end
that would preclude the appropriate seed match base pairing with
cdc-42. Thus, although cdc-42 behaves genetically as a negative
regulator of lin-12, it is not likely to be regulated by mir-250 in an
analogous way to the LIN-12-mir-61-VAV-1 circuit.
Discussion
We have described here two negative regulators of lin-12/Notch
activity, sel-11 and cdc-42. We discuss possible mechanisms by
which these genes may influence lin-12/Notch activity in terms of
our findings and relevant literature on their mammalian orthologs.
SEL-11/Hrd1p and a previously-described negative regulator,
SEL-1/Hrd3p [15,16], are both involved in the Hrd1p pathway of
ER-associated degradation (ERAD). The Hrd1p pathway specif-
ically targets proteins with misfolded lumenal domains for
degradation. SEL-11/Hrd1p is the central E3 ubiquitin ligase,
and SEL-1/Hrd3p acts in the recognition of terminally misfolded
substrates [22,23]. All lin-12 alleles that display genetic interactions
with sel-1 and sel-11 [8,15,16] carry mutations that alter the
extracellular domain, which would be positioned in the ER lumen
during protein synthesis and folding [24,25]. Loss of the Hrd1p
quality control system likely increases the stability or export of
these mutant LIN-12 proteins.
There is some evidence that increased expression of SEL1L, the
human SEL-1 ortholog, correlates with a decrease in tumor
aggressiveness (reviewed in [4]), but if this correlation reflects
effects on Notch activity is not clear. In addition, the human SEL-
11 ortholog, Synoviolin, is essential for development in mice and
has been implicated in hyperproliferation of synovial tissues in
rheumatoid arthritis and in the degradation of p53 and IRE1
[26,27,28]; furthermore, there appears to be multiple modes of
crosstalk between Notch and p53 [29]. These observations are
consistent with the possibility that loss of sel-11 might lead to
elevated LIN-12/Notch activity in cancer.
C. elegans CDC-42 is a member of the Cdc42 subfamily of Rho
family GTPases. Cdc42 has been implicated in many different
cellular processes including polarity, cytoskeleton reorganization,
vesicle trafficking, and signal transduction [30,31]. The VPCs are
polarizedepithelialcells,withLIN-12localized to the apicaldomain
[32] and LET-23/EGFR localized to the basolateral domain [33].
Reciprocal negative regulation of endocytosis and trafficking of
these receptors helps ensure proper pattern formation
[11,34,35,36,37,38,39]. CDC-42 may contribute to this regulation
through effects on VPC polarization and apical membrane
organization, or through a general effect on endocytic traffic
[40,41,42]. CDC-42 may affect LIN-12 signaling per se or through
promoting the activity of the LET-23/EGFR-Ras-MAPK pathway:
although genetic enhancement of lin-12(d) mutations was observed
in the absence of the anchor cell, the normal source of inductive
signal, it is possible that VAV-1 and CDC-42 affect a basal activity
of LET-23 or another receptor tyrosine kinase that promotes Ras
activity.
Cancer results from aberrations in cell-cell interactions and
growth control, processes that are influenced by Notch activity.
Depending on the cellular context, Notch can function as either a
tumor suppressor (promoting differentiation) or proto-oncogene
(promoting proliferation and/or suppressing apoptosis) [3]. In
these roles, Notch crosstalks with p53 and Rho/CDC42 effectors
[29,43]. Our results raise the possibility that Cdc42 has effects on
tumorigenesis through effects on Notch activity.
As mentioned in RESULTS, all of the lin-12 alleles used in this
study carry missense mutations that alter the extracellular domain
and cause constitutive LIN-12 activity; in some cases, the lin-12
alleles are composites of such activating mutations combined with
second-site revertants that lower lin-12 activity. The missense
activating alleles alter a negative regulatory domain [24] now
known to be revealed under normal conditions by ligand binding
(reviewed in [44]). Equivalent missense mutations in human Notch1
cause T-ALL and perhaps other cancers [45]. Whether SEL-11/
Hrd1p/Synoviolin and CDC-42/Cdc42p act to promote the
activity of wild-type LIN-12/Notch or only these missense mutant
forms is not clear. Nevertheless, the clear effect on the LIN-12/
Notch missense mutant forms associated with cancer suggest that
the reduction in the activity of these negative regulators may be
associated with cancer formation or progression.
Materials and Methods
Strains and genetic analysis
Caenorhabditiselegans var. Bristol strain N2 was the wild-type parent
strain of all mutants and markers used. Key strains used herein
were: GS4944 nDf59 (backcrossed to N2 4x), GS4420 ayIs4 [egl-
17::gfp], GS5043 ayIs4; nDf59, GS5775 nIs106 [lin-11p::gfp],
GS5009nDf59;nIs106,GS3804pha-1(e2123);arIs101[K09H11.1p::yfp],
GS5010 nDf59; arIs101, GS5161 unc-32(e189); arIs51[cdh-3::gfp]; nDf59,
GS4894 unc-32(e189)lin-12(n676n930); arIs51, GS5015 unc-32(e189)lin-
12(n676n930); arIs51; nDf59, GS5014 unc-32(e189)lin-12(n676n930);
nIs106, GS5077 unc-32(e189)lin-12(n676n930); nDf59; nIs106, GS3067
unc-32(e189)lin-12(n676n930), GS5186 unc-32(e189)lin-12(n676n930);
hrd-1(tm1743) V, GS104 unc-32(e189)lin-12(n676n930); sel-11(ar39),
GS257 unc-32(e189)lin-12(n676n930); sel-11(ar84), GS3196 lin-
12(n379), GS23 lin-12(n676), GS4481 lin-12(n676); nIs106 [lin-
11p::gfp], GS5098 lin-12(n676); lin-3(e1417); nIs106.
GE24 pha-1(e2123) was used as the recipient to create transgenes. All
strains were grown using standard procedures at 20uC unless otherwise
noted, except for strains with pha-1(+)-containing transgenes in the pha-
1(e2123) background, which were maintained at 25uC. For strains that
were scored at 25uCo r1 5 uC, animals were maintained at the
temperature of interest for at least two generations prior to scoring.
A strain carrying hrd-1(tm1743), backcrossed 4 times, was the
gift of S. Arur and T. Schedl.
Transgenic lines
cdc-42p::2nls-yfp::unc-54 39UTR reporter lines were made by
injecting fusion PCR products [46] into pha-1(e2123) animals: pha-
Negative Regulators of lin-12
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e118851(e2123); arEx843-847 [cdc-42p::2nls-yfp::unc-54 39UTR (0.2 ng/ul),
pBX (50 ng/ul)].
Fusion PCR products and plasmids
Fusion PCR was performed as reported [46]. ‘A’ primers and
‘B’ primers are forward and reverse primers, respectively, used to
amplify promoter regions. ‘A*’ primers are nested forward primers
used with the D* primer (see [46]) for the fusion step. The
following primers were used to amplify the cdc-42 59 region: AY56-
A (CAATGGGCGATCAGGGTGTCTAT), AY56-A* (GCTAA-
TAACCCGCACGGAGTAATG), AY56-B (agtcgacctgcaggcatg-
caagctACTTGATCGTCTGCTTTTCGCCTG).
RNAi experiments
Feeding RNAi experiments were performed at 20uCa s
described [47,48]. Briefly, gravid adults were bleached and the
eggs were placed on plates seeded with HT115 cells expressing the
dsRNA of interest. T7 polymerase expression in the HT115 cells
had been induced with 6 mM IPTG for at least four hours at room
temperature before plating the eggs. To score the number of
pseudovulvae at the adult stage, animals were scored three days
after eggs were placed on plates. To score at the L3 Pn.pxx stage,
animals were scored roughly 45 hours after eggs were plated.
Imaging
All microscopy done on live animals was performed on a Zeiss
Axioplan2 microscope, with a consistent exposure time used for
each marker assayed.
Sequencing the hrd-1 genomic region of sel-11 alleles
The full genomic region of hrd-1, gene-to-gene, was amplified by
PCR in two fragments for sequencing, using the primer pairs hrd-1-
F1 (ATTGATATGGCACATTCAGAGCTTG)/hrd-1-R1 (GT-
TGTTGTGGAAATCCAAACTGATG), and hrd-1-F2 (CATT-
GTCTCCGCAGTTGGTTCC)/hrd-1-R2 (CATCGTCCTCTT-
TTTGTTCTGCTG). Two different alleles of sel-11, sel-11(ar39)
and sel-11(ar84), were associated withtwo different alterations in the
hrd-1 gene (see RESULTS). We note also that strains lacking sel-11
alleles but containing ‘‘sel(arX)’’, a mutation that is in the
background of some strains [8], did not contain any alterations in
the hrd-1 gene.
Confirmation of deletion breakpoints for nDf59 and
tm1743
Genomic DNA was extracted from backcrossed nDf59 and tm1743
strains, and the full genomic region of hrd-1 was amplified by PCR
using the two primer pairs hrd-1-F1/hrd-1-R1, hrd-1-F2/hrd-1-R2
noted in the previous section. The deletion breakpoints for nDf59 and
tm1743 reported in WormBase (www.wormbase.org) were verified by
sequencing. In summary, nDf59 removes 1143 bp, and the deletion
breakpoints for nDf59 are TGGATTTCCACAACAACCAGCT-
GGTGCC/GGAGGTGCTCAGCCTGG… GTTCTAGTCATT-
GCC/ATACGGAGGAAGGACTAAGC. tm1743 is a 473 bp dele-
tion with a 38 bp insertion: the deletion breakpoints are TCATGTTC-
CAATTGCTCAAGTCT/ATTTTATTCGGAGAT TTGAGAG…
CTTAGGAATCCTCAATCTTGGGA/TAACAAAGCCGTTTA-
CCTGCTCT, and CAAAGTTTCTTGTATATCTCATGTTCCA-
ATTGCTCAAG is inserted. The published information about nDf59
only notes that mir-61/250 is deleted [12], but F55A11.3/hrd-1 is also
affected (see WormBase and Fig. 2A).
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